These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20392260)

  • 1. Calmodulin-an often-ignored signal in osteoclasts.
    Williams JP; Micoli K; McDonald JM
    Ann N Y Acad Sci; 2010 Mar; 1192(1):358-64. PubMed ID: 20392260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca
    Liu W; Le CC; Wang D; Ran D; Wang Y; Zhao H; Gu J; Zou H; Yuan Y; Bian J; Liu Z
    Toxicology; 2020 Aug; 441():152520. PubMed ID: 32522522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of calmodulin in the regulation of osteoclastogenesis.
    Zhang L; Feng X; McDonald JM
    Endocrinology; 2003 Oct; 144(10):4536-43. PubMed ID: 12960067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel diether compounds inhibiting differentiation of osteoclasts.
    Doh KE; Kang JH; Ting Z; Yim M; Choo HP
    Arch Pharm Res; 2016 Feb; 39(2):178-190. PubMed ID: 26670177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass.
    Masuyama R; Mizuno A; Komori H; Kajiya H; Uekawa A; Kitaura H; Okabe K; Ohyama K; Komori T
    J Bone Miner Res; 2012 Aug; 27(8):1708-21. PubMed ID: 22492541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats.
    Hsiao CY; Chen TH; Chu TH; Ting YN; Tsai PJ; Shyu JF
    Front Endocrinol (Lausanne); 2020; 11():613. PubMed ID: 33013696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorine-contained hydroxyapatite suppresses bone resorption through inhibiting osteoclasts differentiation and function in vitro and in vivo.
    Liu S; Zhou H; Liu H; Ji H; Fei W; Luo E
    Cell Prolif; 2019 May; 52(3):e12613. PubMed ID: 30968984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu maxim.
    Xue L; Jiang Y; Han T; Zhang N; Qin L; Xin H; Zhang Q
    J Ethnopharmacol; 2016 Nov; 192():370-381. PubMed ID: 27422162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss.
    Du YY; Zhao YX; Liu YP; Liu W; Wang MM; Yuan CM
    Biomed Pharmacother; 2015 Mar; 70():170-3. PubMed ID: 25776497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosylphosphorylcholine blocks ovariectomy-induced bone loss by suppressing Ca
    Lee HY; Cho KM; Kim MK; Lee M; Kim H; Choi CY; Kim KK; Park JS; Kim HH; Bae YS
    J Cell Mol Med; 2021 Jan; 25(1):473-483. PubMed ID: 33230972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.
    Wang JW; Yeh CB; Chou SJ; Lu KC; Chu TH; Chen WY; Chien JL; Yen MH; Chen TH; Shyu JF
    J Bone Miner Metab; 2018 Sep; 36(5):508-518. PubMed ID: 28983668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
    El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
    Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of zoledronate on protein interaction between Ca(2+)/calmodulin-dependent protein kinaseⅡ and calmodulin and expression of downstream genes during osteoclast differentiation].
    Wang H; Dong W; Qi MC; Sun H; Feng XJ; Wen LM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Feb; 52(2):120-125. PubMed ID: 28253589
    [No Abstract]   [Full Text] [Related]  

  • 15. The calcium-sensing receptor in bone metabolism: from bench to bedside and back.
    Cianferotti L; Gomes AR; Fabbri S; Tanini A; Brandi ML
    Osteoporos Int; 2015 Aug; 26(8):2055-71. PubMed ID: 26100412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways.
    Hurtel-Lemaire AS; Mentaverri R; Caudrillier A; Cournarie F; Wattel A; Kamel S; Terwilliger EF; Brown EM; Brazier M
    J Biol Chem; 2009 Jan; 284(1):575-584. PubMed ID: 18927086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis.
    Matsumoto T; Nagase Y; Iwasawa M; Yasui T; Masuda H; Kadono Y; Nakamura K; Tanaka S
    Arthritis Rheum; 2011 Dec; 63(12):3908-17. PubMed ID: 21898348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo.
    Han B; Geng H; Liu L; Wu Z; Wang Y
    Biomed Pharmacother; 2020 Aug; 128():110305. PubMed ID: 32485573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolactin A protects against LPS-induced bone loss by regulation of bone remodeling.
    Sapkota M; Gao M; Li L; Yang M; Shrestha SK; Choi H; Soh Y
    Eur J Pharmacol; 2020 Sep; 883():173305. PubMed ID: 32673673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of zoledronate on osteoclast differentiation and gene expression of calmodulin and calmodulin-dependent protein kinase II].
    Li P; Lin JS; Zhang P; Dong W; Li JY; Qi MC
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Nov; 48(11):694-8. PubMed ID: 24513077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.